Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Very low birth weight infants qualifying for a ‘late’ erythrocyte transfusion: Does giving darbepoetin along with the transfusion counteract the transfusion's erythropoietic suppression?

Abstract

Objective:

Red blood cell (RBC) transfusions can suppress erythropoiesis. On this basis, RBC transfusions administered to very low birth weight (VLBW) neonates potentially render them more likely to qualify for a subsequent transfusion.

Study Design:

We hypothesized that ‘late’ (>14 days after birth) RBC transfusions given to VLBW neonates result in a decrease in reticulocyte count persisting for at least 7 to 10 days. We also hypothesized that a single dose of darbepoetin given along with the transfusion would have the opposite effect, increasing the reticulocyte count for at least 7 to 10 days. To test this, we conducted a single-centered randomized trial with 20 VLBW neonates who, according to our transfusion guidelines, qualified for a late transfusion.

Result:

VLBW infants about to receive a late RBC transfusion were randomized (1:1) to also receive vs not receive (controls) a single subcutaneous dose of darbepoetin (10 μg kg−1). Reticulocyte counts diminished significantly in the controls (a drop of 85±62 × 103 μl−1 (mean±s.d.) at 7 to 10 days), but increased significantly in the darbepoetin recipients (an increase of 177±120 × 103 μl−1 at 7 to 10 days, P<0.0001). At 7 to 10 days after the transfusion, hematocrits of the controls were 8.1±4.9 points above their pre-transfusion values and of the darbepoetin group were 12.4±2.7 points above their pre-transfusion values (P=0.033).

Conclusion:

This was a limited-scope, single-centered, randomized trial intended to pilot-test a new concept in neonatal transfusion practice. Namely, we tested whether a late RBC transfusion suppressed reticulocytosis and whether a concomitant single dose of darbepoetin counteracted that suppression. Using the pilot data presented in this study, larger trials can now be designed to address meaningful clinical outcomes such as transfusion avoidance using this approach.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Luban NLC . Transfusion of blood and blood products. In: MacDonald and Ramasethu (eds). Atlas of Procedures in Neonatology, 4th edn. Lippincott/Williams & Wilkins: Philadelphia, 2007, pp 317–328.

    Google Scholar 

  2. New HV, Stanworth SJ, Engelfriet CP, Reesink HW, McQuilten ZK, Savoia HF et al. Neonatal transfusions. Vox Sang 2009; 96: 62–85.

    Article  CAS  Google Scholar 

  3. Strauss RG . How I transfuse red blood cells and platelets to infants with the anemia and thrombocytopenia of prematurity. Transfusion 2008; 48: 209–217.

    Article  Google Scholar 

  4. Murray NA, Roberts IAG . Neonatal transfusion practice. Arch Dis Child Fetal Neonatal Ed 2004; 89: 101–107.

    Article  Google Scholar 

  5. Dodd R, Kurt Roth W, Ashford P, Dax EM, Vyas G . Transfusion medicine and safety. Biologicals 2009; 37: 62–70.

    Article  Google Scholar 

  6. Stainsby D, Faber J-C, Jorgensen J . Overview of hemovigilance. In: Simon TL, Soleihm BG, Strauss RG, Snyder EL, Petrides M (eds). Rossi's Principles of Transfusion Medicine, 4th edn. Wiley-Blackwell: Bethesda, MD, 2009, pp 683–698.

    Google Scholar 

  7. Millard DD, Gidding SS, Socol ML, MacGregor SN, Dooley SL, Ney JA et al. Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization. Pediatrics 1990; 117: 447–454.

    Article  CAS  Google Scholar 

  8. Wulff H, Wichmann HE, Pantel K, Loeffler M . A mathematical model of erythropoiesis in mice and rats. Part 3: Suppressed erythropoiesis. Cell Tissue Kinet 1989; 22: 51–61.

    CAS  PubMed  Google Scholar 

  9. Wiktor-Jedrzejczak W . Erythropoietic stimulation enhances, and erythropoietic inhibition suppresses, multidirectional differentiation in 4-day transient endogenous spleen colonies. Experientia 1981; 37: 1024–1026.

    Article  CAS  Google Scholar 

  10. Jelkmann W . Effects of erythropoietin on brain function. Curr Pharm Biotechnol 2005; 6: 65–79.

    Article  CAS  Google Scholar 

  11. McPherson RJ, Juul SE . Erythropoietin for infants with hypoxic-ischemic encephalopathy. Curr Opin Pediatr 2010; 22: 139–145.

    Article  Google Scholar 

  12. Bierer R, Peceny MC, Hartenberger CH, Ohls RK . Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 2006; 118: e635–e640.

    Article  Google Scholar 

  13. Testa U . Erythropoietic stimulating agents. Exopert Opin Emerg Drugs 2010; 15: 119–138.

    Article  CAS  Google Scholar 

  14. Song S, Long SR, Marder WE, Sullivan SD, Kallich J . The impact of methodological approach on cost findings in comparison of epoetin alfa with darbepoetin alfa. Ann Pharmacother 2009; 43: 1203–1210.

    Article  CAS  Google Scholar 

  15. Warwood TL, Ohls RK, Lambert DK, Jones C, Scoffield SH, Gupta N et al. Intravenous administration of darbepoetin to NICU patients. J Perinatol 2006; 26: 296–300.

    Article  CAS  Google Scholar 

  16. Warwood TL, Ohls RK, Lambert DK, Leve EA, Veng-Pedersen P, Christensen RD . Urinary excretion of darbepoetin after intravenous vs. subcutaneous administration to preterm neonates. J Perinatol 2006; 26: 636–639.

    Article  CAS  Google Scholar 

  17. Warwood TL, Ohls RD, Wiedmeier SE, Lambert DK, Jones C, Scoffield SH et al. Single-dose darbepoetin administration to anemic preterm neonates. J Perinatol 2008; 25: 725–730.

    Article  Google Scholar 

  18. Freise JK, Widness JA, Veng-Pedersen P . Erythropoietic response to endogenous erythropoietin in premature very low birth weight infants. J Pharmacol Exp Ther 2010; 332: 229–237.

    Article  CAS  Google Scholar 

  19. Baer VL, Lambert DK, Schmutz N, Henry E, Stoddard RA, Miner C et al. Adherence to NICU transfusion guidelines: data from a multihospital healthcare system. J Perinatol 2008; 28: 492–497.

    Article  CAS  Google Scholar 

  20. Widness JA . Treatment and prevention of neonatal anemia. Neoreviews 2008; 9: 526–533.

    Article  Google Scholar 

  21. Crowley M, Kirpalani H . A rational approach to red blood cell transfusion in the neonatal ICU. Curr Opin Pediatr 2010; 22: 151–157.

    Article  Google Scholar 

  22. Strauss RG . Data-driven blood banking practices for neonatal RBC transfusions. Transfusion 2000; 40: 1528–1540.

    Article  CAS  Google Scholar 

  23. Litty CA . Neonatal red cell transfusions. Immunohematology 2008; 24: 10–14.

    CAS  PubMed  Google Scholar 

  24. Valieva OA, Thomas P, Mayock DE, Juul SE . Effects of transfusions in extremely low birth weight infants: a retrospective study. J Pediatr 2009; 155: 331–337.

    Article  Google Scholar 

  25. Sanchez R, Toy P . Transfusion related acute lung injury: a pediatric perspective. Pediatr Blood Cancer 2005; 45: 248–255.

    Article  Google Scholar 

  26. Christensen RD, Lambert DK, Henry E, Wiedmeier SE, Snow GL, Baer VL, et al. Is ‘transfusion-associated necrotizing enterocolitis’ an authentic pathogenic entity? Transfusion 2010; 50: 1106–1112.

    Article  Google Scholar 

  27. Rühl H, Bein G, Sachs UJ . Transfusion-associated graft-versus-host disease. Transfus Med Rev 2009; 23: 62–71.

    Article  Google Scholar 

  28. Wardrop CAJ, Holland BM, Veale KEA, Jones JG, Gray OP . Nonphysiological anemia of prematurity. Arch Dis Child 1978; 53: 855–860.

    Article  CAS  Google Scholar 

  29. Stockman III JA, Garcia JF, Oski FA . The anemia of prematurity. Factors governing the erythropoietin response. N Engl J Med 1977; 296: 647–650.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Nancy Schmutz, RN, for her assistance with the Institutional Review Board application, and Scott Scoffield, PharmD, of the Pharmacy Department and the NICU nursing staff at the McKay-Dee Hospital Center for their valuable assistance in conducting this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R D Christensen.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Warwood, T., Lambert, D., Henry, E. et al. Very low birth weight infants qualifying for a ‘late’ erythrocyte transfusion: Does giving darbepoetin along with the transfusion counteract the transfusion's erythropoietic suppression?. J Perinatol 31 (Suppl 1), S17–S21 (2011). https://doi.org/10.1038/jp.2010.165

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2010.165

Keywords

This article is cited by

Search

Quick links